Aandelen in “Fabricage van farmaceutische preparaten”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Fabricage van farmaceutische preparaten”

10/03 · FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment · Persbericht

10/03 · FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment · Persbericht

10/03 · Moleculin to Present at the 37th Annual ROTH Conference · Persbericht

10/03 · Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors · Persbericht

10/03 · Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients · Persbericht

10/03 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

10/03 · Sun Pharma to Acquire Checkpoint Therapeutics · Persbericht

8/03 · Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD · Persbericht

8/03 · Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study · Persbericht

8/03 · Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis · Persbericht

7/03 · Lilly's EBGLYSS® (lebrikizumab-lbkz) single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis · Persbericht

7/03 · Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK · Persbericht

7/03 · Levi & Korsinsky Notifies Shareholders of Intellia Therapeutics, Inc.(NTLA) of a Class Action Lawsuit and an Upcoming Deadline · Persbericht

7/03 · Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK · Persbericht

7/03 · Levi & Korsinsky Notifies Shareholders of Intellia Therapeutics, Inc.(NTLA) of a Class Action Lawsuit and an Upcoming Deadline · Persbericht

7/03 · ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX · Persbericht

6/03 · Regeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

6/03 · Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity · Persbericht

6/03 · HyBryte™ Treatment Studies Presented at Two Medical Conferences in March · Persbericht

6/03 · ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS · Persbericht

6/03 · Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase · Persbericht

Mijn selecties